Search Results - "GRIEKEN, Nct Van"

Gastric cancer by Smyth, Elizabeth C, Nilsson, Magnus, Grabsch, Heike I, van Grieken, Nicole CT, Lordick, Florian

“…Gastric cancer is the fifth most common cancer and the third most common cause of cancer death globally. Risk factors for the condition include Helicobacter…”
Get full text

Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up by Obermannová, R., Alsina, M., Cervantes, A., Leong, T., Lordick, F., Nilsson, M., van Grieken, N.C.T., Vogel, A., Smyth, E.C.

“…•This ESMO Clinical Practice Guideline provides key recommendations for managing oesophageal cancer.•The guideline covers clinical and pathological diagnosis,…”
Get full text

Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial by de Steur, W.O., van Amelsfoort, R.M., Hartgrink, H.H., Putter, H., Meershoek-Klein Kranenbarg, E., van Grieken, N.C.T., van Sandick, J.W., Claassen, Y.H.M., Braak, J.P.B.M., Jansen, E.P.M., Sikorska, K., van Tinteren, H., Walraven, I., Lind, P., Nordsmark, M., van Berge Henegouwen, M.I., van Laarhoven, H.W.M., Cats, A., Verheij, M., van de Velde, C.J.H.

“…The Intergroup 0116 and the MAGIC trials changed clinical practice for resectable gastric cancer in the Western world. In these trials, overall survival…”
Get full text

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS) by Dikken, Johan L, van Sandick, Johanna W, Maurits Swellengrebel, H A, Lind, Pehr A, Putter, Hein, Jansen, Edwin P M, Boot, Henk, van Grieken, Nicole C T, van de Velde, Cornelis J H, Verheij, Marcel, Cats, Annemieke

“…Radical surgery is the cornerstone in the treatment of resectable gastric cancer. The Intergroup 0116 and MAGIC trials have shown benefit of postoperative…”
Get full text

Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial by Slagter, Astrid E., Tudela, Benjamin, van Amelsfoort, Romy M., Sikorska, Karolina, van Sandick, Johanna W., van de Velde, Cornelis J.H., van Grieken, Nicole C.T., Lind, Pehr, Nordsmark, Marianne, Putter, Hein, Hulshof, Maarten C.C.M., van Laarhoven, Hanneke W.M., Grootscholten, Cecile, Braak, Jeffrey P.B.M., Meershoek-Klein Kranenbarg, Elma, Jansen, Edwin P.M., Cats, Annemieke, Verheij, Marcel

“…To evaluate treatment-related toxicity, treatment compliance, surgical complications and event-free survival (EFS) in older (≥70 years) versus younger (<70…”
Get full text

Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer by Slagter, Astrid E, Caspers, Irene A, van Grieken, Nicole C T, Walraven, Iris, Lind, Pehr, Meershoek-Klein Kranenbarg, Elma, Grootscholten, Cecile, Nordsmark, Marianne, van Sandick, Johanna W, Sikorska, Karolina, van de Velde, Cornelis J H, Jansen, Edwin P M, Verheij, Marcel, van Laarhoven, Hanneke W M, Cats, Annemieke

“…(1) Background: Perioperative chemotherapy is the current standard treatment for patients with resectable gastric cancer. Based on studies in patients with…”
Get full text

Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial by Slagter, Astrid E., Sikorska, Karolina, Grootscholten, Cecile, Laarhoven, Hanneke W. M., Lind, Pehr, Nordsmark, Marianne, Meershoek‐Klein Kranenbarg, Elma, Velde, Cornelis J. H., Grieken, Nicole C. T., Sandick, Johanna W., Jansen, Edwin P. M., Verheij, Marcel, Cats, Annemieke

“…Background The occurrence of a venous thromboembolism (VTE) is common in patients with cancer. Gastric cancer has been associated with one of the highest risks…”
Get full text

Childhood brain tumours due to germline bi-allelic mismatch repair gene mutations by Johannesma, PC, van der Klift, HM, van Grieken, NCT, Troost, D, te Riele, H, Jacobs, MAJM, Postma, TJ, Heideman, DAM, Tops, CMJ, Wijnen, JT, Menko, FH

“…Johannesma PC, van der Klift HM, van Grieken NCT, Troost D, te Riele H, Jacobs MAJM, Postma TJ, Heideman DAM, Tops CMJ, Wijnen JT, Menko FH. Childhood brain…”
Get full text

Gastric cancers in young and elderly patients show different genomic profiles by Buffart, TE, Carvalho, B, Hopmans, E, Brehm, V, Kranenbarg, E Klein, Schaaij-Visser, TBM, Eijk, PP, van Grieken, NCT, Ylstra, B, van de Velde, CJH, Meijer, GA

“…Although most gastric cancers occur in elderly patients, a substantial number of cases of this common disease occur in young patients. Gastric cancer is a…”
Get full text

Gastric cancer – Authors' reply by Hartgrink, HH, Jansen, EPM, van Grieken, NCT, van de Velde, CJH

Get full text

EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients with resected gastric cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1)—An open-label randomized controlled phase II study by Smyth, Elizabeth Catherine, Peeters, Ellen, Knoedler, Maren Kristina, Giraut, Anne, Wagner, Anna Dorothea, Moehler, Markus H., van Grieken, Nicole C.T., Nilsson, Magnus, Mauer, Murielle E., Lordick, Florian

“…Abstract only TPS4156 Background: Gastroesophageal adenocarcinoma (GEA) patients with metastatic lymph nodes (ypN+) or a microscopically incomplete surgical…”
Get full text

Risk factors of metachronous peritoneal carcinomatosis after potentially curative gastric cancer resection in the CRITICS trial by Caspers, Irene A, Sikorska, Karolina, Slagter, Astrid E., Meershoek – Klein Kranenbarg, Elma, Van De Velde, Cornelis J.H., Lind, Pehr A., Nordsmark, Marianne, Jansen, Edwin PM, Verheij, Marcel, van Sandick, Johanna W., Cats, Annemieke, van Grieken, Nicole C.T.

“…Abstract only 4053 Background: Peritoneal carcinomatosis (PC) is accountable for over 50% of metastatic spread in gastric cancer (GC). Little is known about…”
Get full text

EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients with resected gastric cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): An open-label randomized controlled phase II study by Smyth, Elizabeth Catherine, Knoedler, Maren Kristina, Nilsson, Magnus, Wagner, Anna Dorothea, Moehler, Markus H., van Grieken, Nicole C.T., Giraut, Anne, Mauer, Murielle E., Lordick, Florian

“…Abstract only TPS467 Background: Gastroesophageal adenocarcinoma patients with metastatic lymph nodes (ypN+) or a microscopically incomplete surgical resection…”
Get full text

The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial by Caspers, Irene A., Slagter, Astrid E., Lind, Pehr, Sikorska, Karolina, Wiklund, Katja, Pontén, Fredrik, Nordsmark, Marianne, Velde, Cornelis J. H., Kranenbarg, Elma Meershoek‐Klein, Sandick, Johanna W., Jansen, Edwin P. M., Laarhoven, Hanneke W. M., Verheij, Marcel, Grieken, Nicole C. T., Cats, Annemieke

“…Background and Objective This study aims to investigate the impact of sex on outcome measures stratified by histological subtype in patients with resectable…”
Get full text

Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial by Slagter, Astrid E., Vollebergh, Marieke A., Caspers, Irene A., van Sandick, Johanna W., Sikorska, Karolina, Lind, Pehr, Nordsmark, Marianne, Putter, Hein, Braak, Jeffrey P. B. M., Meershoek-Klein Kranenbarg, Elma, van de Velde, Cornelis J. H., Jansen, Edwin P. M., Cats, Annemieke, van Laarhoven, Hanneke W. M., van Grieken, Nicole C. T., Verheij, Marcel

“…Aim To evaluate the prognostic value of tumor markers in a European cohort of patients with resectable gastric cancer. Methods We performed a post hoc analysis…”
Get full text

Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers by de Cuba, E.M.V., Snaebjornsson, P., Heideman, D.A.M., van Grieken, N.C.T., Bosch, L.J.W., Fijneman, R.J.A., Belt, E., Bril, H., Stockmann, H.B.A.C., Hooijberg, E., Punt, C.J.A., Koopman, M., Nagtegaal, I.D., Coupé, V.H.M., Carvalho, B., Meijer, G.A.

“…Microsatellite instability (MSI) has been associated with favourable survival in early stage colorectal cancer (CRC) compared to microsatellite stable (MSS)…”
Get full text

Effect of preoperative chemotherapy on the histopathological classification of gastric cancer by Caspers, I. A., Biesma, H. D., Wiklund, K., Pontén, F., Lind, P., Nordsmark, M., Sikorska, K., Meershoek-KleinKranenbarg, E., Hartgrink, H. H., van de Velde, C. J. H., van Sandick, J. W., Verheij, M., Cats, A., van Grieken, N. C. T.

“…Background In the era of individualized gastric cancer (GC) treatment, accurate determination of histological subtype becomes increasingly relevant. As yet, it…”
Get full text

A comparison of elderly versus nonelderly patients in the CRITICS gastric cancer trial by Slagter, Astrid E, Tudela, Benjamín, van Amelsfoort, Romy, Sikorska, Karolina, van Sandick, Johanna W., Van De Velde, Cornelis J. H., van Grieken, Nicole C.T., Lind, Pehr A., Nordsmark, Marianne, Putter, Hein, Meershoek – Klein Kranenbarg, Elma, Jansen, Edwin PM, Cats, Annemieke, Verheij, Marcel

“…Abstract only 81 Background: Although the proportion of elderly cancer patients (pts) increases, few randomized trials provide separate results on this group…”
Get full text

Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial by Caspers, Irene A., Sikorska, Karolina, Slagter, Astrid E., van Amelsfoort, Romy M., Meershoek-Klein Kranenbarg, Elma, van de Velde, Cornelis J. H., Lind, Pehr, Nordsmark, Marianne, Jansen, Edwin P. M., Verheij, Marcel, van Sandick, Johanna W., Cats, Annemieke, van Grieken, Nicole C. T.

“…Gastric cancer (GC) patients at high risk of developing peritoneal metastasis (PM) as a single site of metastasis after curative treatment may be candidates…”
Get full text

Quality of life in the CRITICS study, a multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer by Van Amelsfoort, Romy, Walraven, Iris, Jansen, Edwin PM, Cats, Annemieke, van Grieken, Nicole C.T., Aaronson, Neil K, Boot, Henk, Lind, Pehr A., Meershoek – Klein Kranenbarg, Elma, Nordsmark, Marianne, Putter, Hein, Trip, Anouk Kirsten, van Sandick, Johanna W., Sikorska, Karolina, van Tinteren, Harm, Van De Velde, Cornelis J. H., Verheij, Marcel

“…Abstract only…”
Get full text